Skip to content

Clinical efficacy of sieve injection of methylprednisolone sodium succinate in the treatment of Bell palsy in the acute stage

Clinical efficacy of sieve injection of methylprednisolone sodium succinate in the treatment of Bell palsy in the acute stage

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300067558
Enrollment
Unknown
Registered
2023-01-11
Start date
2020-07-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bell's facial paralysis

Interventions

Experimental group:The ethmoid area is injected with methylprednisolone sodium succinate
Control group:Prednisone acetate tablets for oral administration

Sponsors

Yinchuan Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Bell facial palsy acute stage patients; 2. Meet the diagnostic criteria for Bell's facial palsy; 3. Be between 14-75 years old (including 14 and 75 years old); 4. Unilateral facial paralysis.

Exclusion criteria

Exclusion criteria: 1. Central facial paralysis caused by tumors, cerebrovascular accidents, etc.; 2. Facial paralysis caused by posterior fossa lesions and intracranial metastasis of nasopharyngeal carcinoma; 3. Peripheral facial paralysis caused by complications of mumps or otitis media; 4. Peripheral facial paralysis caused by cranial trauma; 5. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
House-Brackmann grading system,HBGs;Facial Disability Index Scale;Pain relief time behind the ear;incidene of adverse reactions/events;Blood CBC;Liver function;Kidney function;electrocardiogram;

Countries

China

Contacts

Public ContactGuohui Li

Yinchuan Hospital of Traditional Chinese Medicine

klaide@126.com+86 18995006005

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026